Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
about
Using magnetic resonance imaging to assess visual deficits: a reviewCiticoline: A Food Beneficial for Patients Suffering from or Threated with GlaucomaCurrent perspective of neuroprotection and glaucomaCytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future PerspectivesSenile Dementia and Glaucoma: Evidence for a Common LinkCritical pathogenic events underlying progression of neurodegeneration in glaucomaThe role of cerebrospinal fluid pressure in glaucoma and other ophthalmic diseases: A reviewReport on the National Eye Institute Audacious Goals Initiative: Regenerating the Optic NerveDeimination restores inner retinal visual function in murine demyelinating disease.Structural brain MRI studies in eye diseases: are they clinically relevant? A review of current findings.GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patientsA preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathyPigment epithelium-derived factor protects retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction.Association of a polymorphism in the BIRC6 gene with pseudoexfoliative glaucoma.Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosisRegulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c.The potential of annexin-labelling for the diagnosis and follow-up of glaucoma.Proton magnetic resonance spectroscopy ((1)H-MRS) reveals geniculocalcarine and striate area degeneration in primary glaucoma.Retinal blood flow in glaucomatous eyes with single-hemifield damage.Glaucoma management: relative value and place in therapy of available drug treatments.Protection of pattern electroretinogram and retinal ganglion cells by oncostatin M after optic nerve injuryCross-talk between ciliary epithelium and trabecular meshwork cells in-vitro: a new insight into glaucomaEvaluation of Glaucomatous Damage via Functional Magnetic Resonance Imaging, and Correlations Thereof with Anatomical and Psychophysical Ocular Findings.Time-Lapse Retinal Ganglion Cell Dendritic Field Degeneration Imaged in Organotypic Retinal Explant CultureThe Potential of Human Stem Cells for the Study and Treatment of Glaucoma.Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytesCourse of serum autoantibodies in patients after acute angle-closure glaucoma attack.Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage.Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death.Gender difference in the neuroprotective effect of rat bone marrow mesenchymal cells against hypoxia-induced apoptosis of retinal ganglion cells.Neuroprotective effects of VCP modulators in mouse models of glaucoma.Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.Differential up-regulation of Vesl-1/Homer 1 protein isoforms associated with decline in visual performance in a preclinical glaucoma model.Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush ModelGlaucoma and optic nerve repair.Critical assessment of implantable drug delivery devices in glaucoma management.Glaucomatous optic neuropathy management: the role of neuroprotective agents.Present and New Treatment Strategies in the Management of Glaucoma.
P2860
Q26750521-6513F6EE-BD9C-4DDA-A29C-28605BFE2071Q26752575-B1133B12-4927-4F4A-B640-B0F5EB68F395Q26774852-5EE8B8F2-E996-4F22-9942-5C886BC61C43Q26775083-842AFC4B-C695-42DC-9E2F-C2AD82CFC16EQ26783439-FB6450B1-6402-4C72-85DA-96CD38BAE6E4Q26859194-1EBCFA72-D052-4053-959F-A8A19897A821Q27014349-4016BB1C-3588-4A11-8332-7AC07AA30A68Q28073773-0F3246AA-6718-41E8-A759-E86B8B29BD2EQ30533881-A545B4CA-B466-4AF6-9E46-559C653571D9Q30993063-F90DCD82-41C1-4E6E-A3A8-8465ABE4396EQ33631141-2525F85D-D208-44CC-A962-5E9911866723Q33785959-740DE82B-94E7-4E53-847D-A5F586A5AD57Q33912451-C6548D2D-1B43-4B78-925E-D9E9AE6FE148Q34041829-24DBEE7B-40F9-4AB7-8F97-4E80714D87DFQ34294531-C98974A3-5914-464F-B623-FD715223857FQ34525534-5FE74762-0E48-4FD5-8204-ECADAEE96A8EQ34570419-F1C8A0CB-6EDD-4ED7-9387-20D1B110F9D6Q34979746-CCB81E98-B78F-435B-AFF3-FC9DB8877CD4Q35056863-01819C7B-7335-4C83-BDA7-86DB22791286Q35079342-7B67E994-5E89-4299-868E-21C29D9305E2Q35268594-39848EEF-36AB-45F2-8140-4995A16E91FBQ35412562-819E49A3-D2F0-44C3-B713-277B3D0E43F0Q35602198-15ADED3D-172E-4C8A-9C39-6458644D0D54Q35904571-97B16986-CD1B-41D9-BFC7-C12374A0A90EQ35999823-2BA575AF-5A70-4E32-8200-08AD9B2BC8CAQ36005823-04C77A12-5B28-4139-AF38-89561C390007Q36167338-CDEDEC58-26D6-4991-A95B-4DE9D0FC49B9Q36234565-83E59998-4A78-4970-A503-85F10509A2E4Q36673015-620D3DC2-9625-4110-9BE9-BC882A0A6E03Q36996649-D3CA3A90-87BA-4E85-BDF1-805BBC194DC7Q37096830-1D166E2D-7417-40D7-88B9-4DF967391AE8Q37364200-74F05878-A4FB-4C51-A7B8-0C5844DF7E8DQ37473130-46699A79-0DD5-4644-ADD4-8A6D72D5C872Q37556986-6D791415-F5A6-4EFC-AE40-7C3E6F466654Q37645117-E931D8D5-3A8E-4827-A0AD-65F763820E18Q37702027-1A274C33-A25A-44A2-BB8A-5F6EDCCCF3F0Q38091321-8E8D56DA-08B9-46F5-A54A-1F98EEA58F32Q38143069-43AABA73-E6C5-4C0A-8375-354A1A84CA8DQ38193827-48568AA0-D6CD-4590-993F-732B0602F407Q38526185-A03DF889-9644-475E-B758-DF41DF6179B7
P2860
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@ast
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@en
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@nl
type
label
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@ast
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@en
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@nl
prefLabel
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@ast
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@en
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@nl
P2860
P1433
P1476
Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement
@en
P2093
Elma E Chang
P2860
P304
P356
10.1016/J.OPHTHA.2011.11.003
P577
2012-02-18T00:00:00Z